美国纽约艾尔伯特•爱因斯坦医学院招聘癌症方向博后职位

Postdoctoral Opportunities at the Albert Einstein Cancer Center : Bronx, NY, United States

Postdoctoral Opportunities at the Albert Einstein Cancer Center
Albert Einstein College of Medicine

The Albert Einstein Cancer Center is a major NCI-designated research institute with a broad spectrum of interdisciplinary programs and core laboratory facilities. There are research training opportunities encompassed in Cancer Center programs focused on (i) the tumor microenvironment and metastasis with an emphasis on breast cancer, (ii) stem cells, differentiation and cancer with an emphasis on the hematological malignancies, (iii) experimental therapeutics encompassing new drug design and development in the realms of cytotoxic, targeted and immune therapies, (iv) cancer epidemiology with a focus on viral and metabolic causes of cancer and (v) the biology of colorectal cancer. There is close coordination and collaboration with other centers and institutes across disciplines encompassing Einstein’s Institute for Stem Cell and Regenerative Medicine, theNIH-funded Liver, Diabetes and Aging Centers and the Center for AIDS Research.

Laboratory postdoctoral openings:

• Studies on isoform-specific signaling by PI 3-kinase in tumor metastasis.
Jonathan M. Backer, MD – Departments of Molecular Pharmacology and Biochemistry

• Host-Microbe interactions, microbial genetics, metagenomics/metabolomics, inflammation and cancer.
Sridhar Mani, MD – Departments of Genetics and Medicine

• Studies on the pro-metastatic protein S100A4 in host-tumor cell interactions during metastasis.
Anne R. Bresnick, PhD – Department of Biochemistry

• Role of DNA modifying enzymes in epigenetic regulation of normal and malignant hematopoiesis
Meelad Dawlaty, PhD – Department of Genetics

• The role of stem cell programs in breast cancer.
Wenjun Guo, PhD – Department of Cell Biology

• Development of a procedure to cure sickle cell disease by gene modification in LT-HSCs.
• Hematopoietic stem cell aging and expression variability.
Eric Bouhassira, PhD – Departments of Cell Biology and Medicine (Hematology)

• Cell signaling in normal biology and cancer.
Marina Holz, PhD – Department of Molecular Pharmacology

• Regulation and physiological role of Endosomal Microautophagy (eMI) selective for soluble,KFERQ-motif containing substrates, for which we recently have developed a genetic system
Andreas Jenny, PhD – Departments of Developmental & Molecular Biology and Genetics

• Anti-cancer mechanism of methylthioadenosine phosphate inhibitors.
Vern Schramm, PhD – Department of Biochemistry

• New immune checkpoints and cancer immunotherapies.
Xingxing Zang, PhD – Departments of Microbiology/Immunology, Medicine (Oncology) and
Urology

• Molecular and therapeutic Immunomodulation of the immune system to cure HIV infection and prevent neuroAIDS.
Harris Goldstein, MD – Departments of Pediatrics and Microbiology/Immunology

• Development of small molecule drugs to protect the heart during cancer treatments
Richard Kitsis, MD – Departments of Medicine and Cell Biology; Evripidis Gavathiotis, PhD Departments of Biochemistry and Medicine

• Potential differences in gene regulation in lungs and lung tumors among individuals, using genetic and epigenetic techniques.
Simon Spivack, MD, MPH – Departments of Medicine (Pulmonary medicine), Epidemiology & Prevention Health and Genetics

• Molecular analysis of DNA replication and repair at cancer-associated sites in the human genome – Carl Schildkraut, PhD – Professor, Department of Cell Biology